Thomas has been active in the biotech and medtech business for >30 years. He is currently the CEO of Altamira Therapeutics Ltd., a biomedical company developing therapeutics for indications in oncology, neurotology, allergology and infectiology. In this role, he designed and oversaw 14 clinical trials, ranging from Phase 1 to Phase 3. Prior to founding Altamira Therapeutics in 2003, he was the CEO of Disetronic Group, a fast-growing Swiss drug delivery company.
Rebecca has profound knowledge of the clinical research industry since 2008. She started her career as a clinical research associate with a CRO and later became a clinical project manager, clinical operations manager, and finally regional clinical trials manager with leading pharmaceutical/biotech companies. Rebecca recently broadened her skillset with an executive MBA from the Technical University of Munich and is a certified Blockchain/DLT Manager and DLT Talent.
Jennifer is a specialist in creating software solutions in highly regulated markets with over 10 years of experience in developing and leading teams. Her professional career started in the financial industry providing FinTech, RegTech and SupTech products to startups, financial institutions, and regulatory authorities worldwide. This gave her a great foundation for building innovative solutions for the clinical trial space utilizing her leadership skills, entrepreneurial mind, tech and Blockchain/DLT know-how.